Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice

Atherosclerosis. 2018 Oct:277:470-476. doi: 10.1016/j.atherosclerosis.2018.06.822.

Abstract

Background and aims: Familial hypercholesterolaemia (FH) is the commonest monogenic disorder that accelerates atherosclerotic cardiovascular disease. We compared and contrasted the characteristics of patients from three specialist centres in the southern hemisphere.

Methods: Adult index-cases with molecularly diagnosed heterozygous FH attending specialist lipid centres in Cape Town, Perth and São Paulo were studied. Myocardial infarction, revascularisation, hypertension, diabetes, smoking and lipid-lowering treatment were recorded at the time of diagnosis and compared across the three centres.

Results: The spectrum of genetic variants causative of FH was significantly different in patients attending the centres in South Africa compared with Australia and Brazil. Hypertension and diabetes were more prevalent in Brazilian and Australian patients, than in South African patients, but the frequency of smoking was significantly greater in South Africa than the other two centres (p<0.01). Age, male sex and smoking were significant independent predictors of coronary artery disease (CAD) in all three countries (p<0.05).

Conclusions: Patients with FH in three specialist centres in the southern hemisphere exhibit a high prevalence of non-cholesterol cardiovascular disease risk factors. Older age, male sex and smoking were more common among subjects with CAD. In all three countries, there should be vigorous programmes for the control of risk factors beyond good control of hypercholesterolaemia among patients with FH. Promotion of a healthy lifestyle, especially anti-smoking advice, is of paramount importance.

Keywords: Australia; Brazil; Familial hypercholesterolaemia; Heterozygous; South Africa.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Biomarkers / blood
  • Brazil / epidemiology
  • Cholesterol, LDL / blood*
  • Comorbidity
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / genetics
  • Coronary Artery Disease / prevention & control
  • Early Diagnosis
  • Female
  • Genetic Markers
  • Genetic Predisposition to Disease
  • Healthy Lifestyle*
  • Heterozygote
  • Humans
  • Hyperlipoproteinemia Type II / diagnosis*
  • Hyperlipoproteinemia Type II / epidemiology
  • Hyperlipoproteinemia Type II / genetics
  • Hyperlipoproteinemia Type II / therapy*
  • Male
  • Middle Aged
  • Mutation
  • Phenotype
  • Predictive Value of Tests
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Risk Reduction Behavior*
  • Sex Factors
  • Smoking / adverse effects
  • Smoking / epidemiology
  • Smoking Cessation
  • South Africa / epidemiology
  • Western Australia / epidemiology

Substances

  • Biomarkers
  • Cholesterol, LDL
  • Genetic Markers